CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 173 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00005761
NCT00005761N/ACompleted

Study of Association of Serum Factors With Diabetic Retinopathy

National Eye Institute (NEI)·observational·Posted May 29, 2000·Updated Jul 2, 2017

In Brief

An observational study for Diabetic Retinopathy. Completed, enrolled 173 participants across 1 site.

Detailed Summary

This study will determine whether certain factors in the blood are associated with the severity of diabetic retinopathy. Patients age 10 years and older with diabetes mellitus and diabetic retinopathy may be eligible for this study. Those enrolled will represent a range of diabetic retinopathy from minimal to severe. Participants will undergo the following procedures: * medical history * thorough eye examination * photographs of the eye * blood tests to measure blood lipids (cholesterol and triglycerides) and serum creatinine (for kidney function) * blood tests to measure levels of blood factors (cell adhesion molecules, chemokines and vascular endothelial growth factor) that may be related to the progression of diabetic retinopathy * blood pressure measurement * urinalysis This study may lead to a better understanding of how diabetic retinopathy develops and progresses.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 29, 2000
Enrollment StartMay 23, 2000
Study CompletionDec 7, 2010
TodayJul 2, 2026
Posted 26.1 years ago